Sunday 11 October 2026 Export all VTR data to Excel Powerpack

Ventas, Inc.

VTR Real Estate Reit Healthcare Facilities

Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024. In the quarter to June 2026, revenue grew 21.7%, EPS fell 6.67%, free cash flow grew 13.6% and total debt fell 2.82%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for five; insiders bought in the last twelve months.

82.04 0.28 +0.34%
Market cap
$42.9B
P/E
149×
Fwd P/E
133×
Dividend yield
2.49%
F-score
7/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Ventas, Inc. (VTR) EBITDA

Alert me on EBITDA

Ventas, Inc.'s EBITDA for fiscal 2025 was $2.2B, up 16.7% from $1.9B in fiscal 2024. Over the twelve months to 30 June 2026 it was $2.4B. Over the past ten years it has ranged from $1.5B (fiscal 2021) to $2.2B (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 4 consecutive fiscal years. Ventas, Inc. ranks 2nd of 16 Reit Healthcare Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $2.2B 16.73%
FY2024 $1.9B 9.12%
FY2023 $1.8B 6.04%
FY2022 $1.7B 7.29%
FY2021 $1.5B (9.77%)
FY2020 $1.7B (11.11%)
FY2019 $1.9B 1.15%
FY2018 $1.9B (2.62%)
FY2017 $1.9B 4.46%
FY2016 $1.9B 3.07%

Quarterly newest first

Period EBITDA Change
Jun 2026 $643.2M 7.98%
Mar 2026 $595.6M 1.08%
Dec 2025 $589.2M 2.39%
Sep 2025 $575.5M 5.01%
42 more quarters

Against its own ten years

Low $1.5B High $2.2B
Ten-year median $1.9B
Current reading's percentile 100

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on VTR